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Edited by Varda RotterAbstract In general, the activation of extracellular recognition
kinase (ERK) cascade is implicated in exerting tumorigenic
eﬀects. Conversely, recent studies suggest that ERK activation
may also have role in DNA-damage induced apoptosis [Wang,
X., Martindale, J.L. and Holbrook, N.J. (2000) Requirement
for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem.
275, 39435–39443; Schweyer S., Soruri A., Meschter O., Hei-
ntze A., Zschunke F., Miosge N., Thelen P., Schlott T., Radzun
H.J. and Fayyazi, A. (2004) Cisplatin-induced apoptosis in
human malignant testicular germ cell lines depends on MEK/
ERK activation. Br. J. Cancer 91, 589–598]. Here we observed
an essential requirement of ERK activation in carboplatin (Carb)
induced apoptosis in SiHa and CaSki cells. Under similar treat-
ment conditions p53 was also involved in Carb induced apoptosis
in these cells. Therefore, we investigated the relation between
p53 and ERK in Carb induced apoptosis in these cells. Abroga-
tion of p53 transactivation activity by piﬁthrina or dominant-
negative mutant of p53 resulted in decrease in activation of
ERK in Carb treated cells. The present study for the ﬁrst time
proposes that p53 may act as one of the upstream regulators
of ERK activation for the induction of apoptosis in Carb treated
cervical cancer cells.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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kinase; Apoptosis1. Introduction
Carboplatin (Carb) is among the most eﬀective and widely
used chemotherapeutic agents employed for the treatment of
human cancers including cervical carcinoma. Carb induced
cytotoxicity is generally considered to be the result of its ability
to damage DNA [1]. In response to DNA-damage stresses,
various molecular and cellular processes are activated, that
coordinates and transduces incoming signals from stress and
result in the induction of apoptosis. Like other members of
MAP-kinase family, extracellular recognition kinase (ERK)Abbreviations: Carb, carboplatin; ERK, extracellular recognition kin-
ase; CAT, chloramphenicol acetyl transferase; Tyr, tyrosine; EGFR,
epidermal growth factor receptor
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doi:10.1016/j.febslet.2006.12.035is reported to be activated in response to stresses for the induc-
tion of apoptosis [2–10]. Interestingly, these ﬁndings have
reported contrasting role of ERK as the activation of ERK
cascade is originally thought to be associated with prolifera-
tion, diﬀerentiation and survival of the cells [11–13]. The
upstream regulations of ERK cascade in response to DNA
damage stresses which assign the apoptotic role to ERK have
remained unclear.
In response to DNA damage stress, p53 is reported as a cen-
tral mediator of the cellular responses. Since, almost all cervi-
cal cancer cases are found to be infected with high-risk human
papillomaviruses (HPVs), p53 is rapidly degraded by E6 med-
iated ubiquitin-dependent proteolysis in these cells [14,15].
Therefore, p53 expression is very low in cervical cancer cells
[15]. However, in response to DNA damage stress, p53 is sta-
bilized and induced to exert its various cellular responses
including apoptosis [16,17].
Since, there are similarities between ERK and p53 in the cel-
lular response to DNA damage stress; we sought to explore the
relationship between activation of ERK and p53 expression in
Carb induced apoptosis in cervical cancer cell lines SiHa and
CaSki. We report here that Carb activates ERK and p53 in
a time dependent manner. Both, ERK activation as well as
p53 transactivation activity leads to Carb induced apoptosis.
By applying chemical as well as genetic strategies to manipu-
late p53 transactivation activity, our data provide the evidence
that Carb induced p53 leads to the activation of ERK in SiHa
and CaSki cells. Overall, our ﬁndings for the ﬁrst time report
that p53 may represent one of the upstream mediators for
Carb induced ERK activation responsible for the induction
of apoptosis in cervical cancer cells.2. Materials and methods
2.1. Cell culture, reagents and plasmid constructs
SiHa and CaSki cells were obtained from American Type Culture
Collection (Manassas, VA, USA) and maintained in our in-house Na-
tional Cell Repository. SiHa cells were routinely cultured in DMEM
(Sigma, St. Louis, USA) whereas CaSki cells were grown in RPMI-
1640 (Sigma) supplemented with heat inactivated fetal bovine serum
(HyClone, UT, USA) (10%), penicillin (100 U/ml) and streptomycin
(100 lg/ml) (Life Technologies, MD, USA) at 37 C with 5% CO2.
Carb was purchased from Sigma, and dissolved in sterile water to
prepare a stock of 25 mM. Stock solutions were diluted in culture med-
ium immediately before use. U0126 was purchased from Calbiochem
(San Diego, USA) and Piﬁthrina (PFTa) was purchased from Sigma.
Stocks of U0126 and PFTa were prepared in DMSO. Cells were pre-
treated with indicated concentrations of inhibitor 1 h prior to the addi-
tion of Carb and continuously exposed to the inhibitors during the
exposure to Carb.ation of European Biochemical Societies.
290 S. Singh et al. / FEBS Letters 581 (2007) 289–295PG13-CAT which contains 13 repeats of p53 binding site inserted in
the 5 0 to polyomavirus basal promoter linked to CAT reporter gene as
well as p53 dominant-negative expression vector, pC53-SCX3, which
expresses a mutant p53 protein containing a substitution of Ala for
Val-143 was kindly gifted by Dr. Bert Vogelstein, John Hopkins, Bal-
timore, MD.2.2. Imunobloting
SiHa and CaSki cells were treated with Carb at indicated doses or
time durations. Following treatment, cells were washed thrice with
ice cold PBS, lysed and analyzed by Western blotting [18]. The Western
blot analysis of cleaved PARP from a p116 polypeptide to p85 frag-
ment was assessed by using rabbit polyclonal anti-PARP antibody
(H-250) to demonstrate the induction of apoptosis in Carb treated cells
[19]. p53 expression was detected by using HRP conjugated mouse
monoclonal anti-p53 antibody (DO-1). Activation of ERK was
detected by mouse monoclonal anti-phospho-ERK antibody (E-4) to
detect Tyr204 phosphorylation of ERK1 and 2. Basal ERK protein
expression was detected by using rabbit polyclonal antibodies (C-14).
b-Actin expression was detected by using goat polyclonal antibody
(C-11). All the antibodies were purchased from Santa Cruz Biotechnol-
ogy, CA, USA.
2.3. Chloramphenicol acetyl transferase (CAT) assay
The transactivation activity of p53 was estimated in SiHa cells stably
transfected with PG13-CAT reporter construct. Cells were transfected
with Lipofectamine-2000 reagent as suggested by the manufacturer
(Life Technologies). PG13-CAT was cotransfected with vector
pCDNA3 which codes for neomycin resistance. Stable transfectants
were selected with 1000 lg/ml G418 (Life Technologies) for 21 days.
Resistant cells were pooled and termed as SiHa-PG13CAT cells. Cells
were maintained in medium supplemented with 200 lg/ml of G418.Fig. 1. Carb induces ERK phosphorylation which is associated with apop
concentration of Carb for 24 h. (C and D) SiHa and CaSki cells were treate
harvested and equal amount of protein was processed for Western blot an
stripped and reprobed to detect total ERK2. (E and F) SiHa and CaSki cell
concentration of U0126. Cells were harvested and equal amount of protein w
Tyr204-phosphorylation of ERK1 and 2 as well as for total ERK. These reSiHa-PG13CAT cells were platted into 35 mm plates (5 · 105 cells
per plate). After allowing the cells to adhere for 36 h, Carb was added
for the indicated time. Thereafter, cells were collected and resuspended
in 0.25 M Tris (pH 7.5). Cells were disrupted by ﬁve cycles of freeze–
thaw. Equal amount of protein was used for the CAT assay. The
CAT reaction mixture, containing 1 lCi 14C-chloramphenicol (NEN,
Boston, MA) and 100 lg of acetyl CoA (Amersham, Aylesbury,
UK), was incubated at 37 C for 6 h. CAT activity was determined
by measuring the acetylation of 14C-chloramphenicol by thin layer
chromatography. TLC plates were analyzed by autoradiography and
by scanning on a phosphorimager (Bio-Rad, CA, USA).3. Results
3.1. Carb activates ERK in SiHa and CaSki cells which is
associated with the induction of apoptosis
The ERK signaling pathway has been shown to be activated
in response to a variety of DNA-damage stresses [2–10]. To
investigate whether Carb induced DNA damage-stress also
leads to the activation of ERK, SiHa and CaSki cells were
treated with indicated doses of Carb and lysates were pro-
cessed for Western blot analysis to detect Tyr204 phosphoryla-
tion. The same membranes were subsequently stripped and
re-probed with an antibody that recognizes total ERK2
(Fig. 1). As shown in Fig. 1A, and B, SiHa and CaSki cells
were treated with indicated concentrations of Carb. SiHa cells
showed constitutive activity of ERK which decreased subse-
quently at 50 and 200 lM of Carb treatment. However, 500tosis. (A and B) SiHa and CaSki cells were treated with increasing
d with 500 lM of Carb for indicated time. In all the panels, cells were
alysis to detect Tyr204-phosphorylation of ERK1 and 2. Blots were
s were treated with 500 lM of Carb for 30 h with or without indicated
as processed for Western blot analysis to detect the cleavage of PARP,
sults are representative of three independent experiments.
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of ERK in SiHa cells (Fig. 1A). On the other hand, CaSki cells
demonstrated a dose dependent increase in ERK activation in
response to Carb treatment (Fig. 1B).
Next, the time kinetics of ERK activation in response to
500 lM Carb was studied in SiHa and CaSki cells and results
are shown in Fig. 1C and D. SiHa cells showed a biphasic
response of ERK activation in a time dependent manner.
The basal activity of ERK decreased till 12 h of treatment.
Carb reactivated ERK after 18 h of treatment which further
increased till 30 h of treatment (Fig. 1C). On the other hand,
in CaSki cells, the activation of ERK was apparent after 6 h
of treatment and sustained at almost similar level till 18 h fol-
lowing treatment with 500 lM Carb. However, a strong ERK
activation was observed at 24 h which further increased at 30 h
following treatment (Fig. 1D).
As shown by our group and others, Carb treatment induces
apoptotic cell death in variety of cell lines [16,19]. To explore
the functional involvement of ERK activation in Carb induced
apoptosis U0126 was utilized. U0126 is a highly selective
inhibitor of ERK pathway which inhibits the MEK mediated
ERK activation [20,21]. Cells were pretreated with U0126 for
1 h prior to the addition of 500 lMCarb for 30 h. Cells treated
with Carb alone displayed typical features of apoptosis i.e.
shrinkage of the cytoplasm, membrane blebbing and conden-
sation of nuclei, whereas pretreatment of cells with U0126
markedly suppressed the apoptotic features induced by Carb
(data not shown). To conﬁrm that pretreatment with MEK
inhibitor indeed suppresses Carb induced ERK activation
and apoptosis, SiHa and CaSki cells were treated with
500 lM of Carb for 30 h with or without pretreatment of
U0126. As expected, pretreatment with U0126 suppressed
Carb induced PARP cleavage (as demonstrated by decrease
in p85 fragment of PARP) in a dose dependent manner as it
suppressed the activation of ERK (Fig. 1E and F; lanes 3
and 4 as compared to lane 2). Overall, results indicated that
the Carb induced DNA damage stress activates ERK and
the activation of ERK is associated with the induction of
apoptosis in SiHa and CaSki cells.
3.2. Carb induced ERK activation is independent of EGFR
activity
Recent studies have revealed that DNA damage stress like
UV irradiation or cisplatin treatment results in the activation
of ERK in a number of cell types through the activation of epi-
dermal growth factor receptor (EGFR) [22–24]. The EGFR
protein shows intrinsic tyrosine (Tyr) kinase activity which
facilitates the activation of a cascade of biochemical and phys-Fig. 2. Carb induced ERK activation is not regulated by EGFR. (A and B
without 500 lM of Carb for 30 h. Cells were harvested and equal amount of
phosphorylation of ERK1 and 2 as well as for total ERK. These results areiological responses to activate ERK [25,26]. Thus, we next
explored the involvement of EGFR mediated signaling in Carb
induced ERK activation by inhibiting the EGFR kinase activ-
ity through its potent and speciﬁc inhibitor, PD153035.
PD153035 is shown to rapidly suppress the EGF mediated
or the autophosphorylated EGFR tyrosine kinase activity in
a variety of cell lines [26,27]. Both SiHa and CaSki cells were
treated with 1 lM of PD153035 for 30 h and processed for
Western blot analysis to detect the phosphorylation of ERK.
As shown in Fig. 2A and B, inhibition of EGFR kinase activity
by PD153035 resulted in a very signiﬁcant inhibition of basal
activity of ERK in both SiHa and CaSki cells (lane 2 as com-
pared to lane 1). These results indicated that EGFR activity is
responsible for the basal ERK activity in these cells. Next, to
study whether Carb induced ERK is also mediated through
EGFR kinase activity, both SiHa and CaSki cells were pre-
treated with 1 lM of PD153035 for 1 h and subsequently
500 lM Carb was added for 30 h in the presence of inhibitor.
As shown in Fig. 2A and B, Carb induced ERK activation was
not signiﬁcantly inhibited by PD153035 (lane 4 as compared to
lane 3) in both SiHa and CaSki cells. Therefore, these results
imply that Carb induced ERK phosphorylation is independent
of the tyrosine kinase activity of EGFR in SiHa and CaSki
cells.
3.3. Carb induces p53 transactivation activity which is associated
with the induction of apoptosis
In response to DNA damage stress p53 plays a major role in
the induction of apoptosis. We next studied the response of
p53 and its functional signiﬁcance in Carb treated cells. SiHa
and CaSki cells were treated with 500 lM Carb for increasing
time and lysates were processed for Western blot analysis to
detect p53 by using p53 monoclonal antibody (DO-1). Both
SiHa and CaSki cells showed a time dependent response of
p53 after Carb treatment. p53 upregulation was apparent after
6 h of treatment and it further increased after 12 h. SiHa cells
showed sustained p53 levels up to 24 h which decreased after
30 h of treatment (Fig. 3A). On the other hand, CaSki cells
showed the maximum p53 protein levels by 12 h of treatment
which decreased at later time points studied (Fig. 3B). Next,
the transactivation activity of upregulated p53 was checked
in Carb treated cells. SiHa-PG13CAT cells, carrying p53-
CAT reporter construct (PG13CAT) were treated with
500 lM of Carb. Cells were harvested at indicated time
(Fig. 3C) and CAT activity was measured as described in Sec-
tion 2. SiHa cells showed an increased p53 transactivation
activity after 18 h of Carb treatment which further increased
after 24 h of treatment. However, p53 transactivation activity) SiHa and CaSki cells were treated with 1 lM of PD153035 with or
protein was processed for Western blot analysis to detect the Tyr204-
representative of three independent experiments.
Fig. 3. Carb induces p53 transactivation activity which is associated with apoptosis. (A and B) SiHa and CaSki cells were treated with 500 lM of
Carb for indicated time. Cells were harvested and equal amount of protein was processed for Western blot analysis to detect the p53 levels. Blots were
stripped and reprobed with b-Actin antibody to conﬁrm equal loading. (C) SiHa-PG13CAT cells were treated with 500 lM of Carb for indicated time
and p53 transactivation activity was detected by CAT assay. (D) Carb induced p53 transactivation activity was suppressed by the treatment of PFTa
and demonstrated by CAT assay. (E and F) SiHa and CaSki cells were treated with 500 lM of Carb for 30 h with or without indicated concentration
of PFTa. Cells were harvested and equal amount of protein was processed for Western blot analysis to detect the cleavage of PARP. These results are
representative of three independent experiments.
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cated that in SiHa and CaSki cells, Carb treatment not only
results in p53 protein upregulation but also increases p53
transactivation activity.
Restoration of p53 transactivation activity is important to
reestablish the lost function of p53 in HPV-positive cervical
cancer cells. Thus, we next studied the functional role of in-
duced p53 in response to Carb treatment in SiHa and CaSki
cells. A cell permeable and potent inhibitor of p53 transactiva-
tion activity, piﬁthrina (PFTa) [28] was chosen to inhibit the
activity of induced p53 in Carb treated cells. To conﬁrm the
eﬀect of PFTa on p53 transactivation activity, SiHa-PG13CAT
cells were treated with Carb in the presence or absence of
PFTa. Pretreatment with PFTa for 1 h before the addition
of 500 lM of Carb demonstrated a signiﬁcant decrease in
CAT activity as compared to Carb alone treated cells
(Fig. 3D) which conﬁrms the inhibitory eﬀect of PFTa on Carb
induced p53 transactivation activity. Next, to check the signi-
ﬁcance of upregulated p53 transactivation activity in Carb
induced apoptosis, SiHa and CaSki cells were treated with
500 lM of Carb for 30 h with or without the pretreatment of
PFTa at indicated concentrations. In both SiHa and CaSki
cells pretreatment with 30 lM PFTa signiﬁcantly suppressed
Carb induced PARP cleavage as detected by the decrease in
the levels of p85 fragment of PARP (Fig. 3E and F; lane 4
as compared to lane 2). Overall, results so far indicated that
Carb induced p53 as well as ERK activation and both of these
are associated with the induction of apoptosis in SiHa and
CaSki cells.3.4. p53 regulates the activation of ERK in Carb treated cells
In an earlier report p53 transactivation activity has been
linked with the activation of ERK [29]. Next, to explore the
possible role of induced p53 in the activation of ERK in
response to Carb treatment, SiHa and CaSki cells were pre-
treated with indicated doses of PFTa for 1 h followed by the
addition of 500 lM Carb for 30 h in the presence of inhibitor.
Interestingly, in both SiHa and CaSki cells, PFTa pretreat-
ment inhibits the Carb induced ERK activation as compared
to its activation in Carb alone treated cells (Fig. 4A and B; lane
3 or 4 as compared to lane 2).
To conﬁrm whether the Carb induced p53 transactivation
activity is indeed essential for Carb induced ERK phosphory-
lation, p53 transactivation activity was abrogated by a domi-
nant negative mutant of p53. A stable cell line of SiHa cells
was established by transfecting pC53-SCX3 expression vector
to express a dominant-negative mutant of p53 containing a
substitution of Ala for Val-143. Vector transfected (SiHa-
neo) and pC53-SCX3 transfected (SiHa-pC53) cells were ana-
lyzed by Western blot analysis for the expression of p53 in
these cells. As shown in Fig. 4C, SiHa-neo cells (lane 1) dem-
onstrated the minimum expression of p53 where as SiHa-pC53
cells (lane 2) showed a very high expression of p53, which is a
mixture of wild-type as well as expressed mutant p53. Both
these cells were treated with 500 lM of Carb for various time
points and time depended response of ERK activation was
analyzed. As shown in Fig. 4D, SiHa-neo cells demonstrated
an almost similar time dependent response as shown by SiHa
parental cells (Fig. 1C). In contrast to these observations,
Fig. 4. p53 transactivation activity regulates Carb mediated ERK activation. (A and B) SiHa and CaSki cells were treated with 500 lM of Carb for
30 h with or without indicated concentration of PFTa. Cells were harvested and equal amount of protein was processed for Western blot analysis to
detect the activation of ERK1 and 2. Blots were stripped and reprobed to detect ERK2. (C) Equal amount of protein from SiHa-neo (lane 1) and
SiHa-pC53 (lane 2) cells was detected for the expression of p53 in the cells. Blots were stripped and reprobed for b-actin to conﬁrm equal loading. (D)
SiHa-neo and SiHa-pC53 cells were treated with 500 lM of Carb for indicated time. Cells were harvested and equal amount of protein was processed
for Western blot analysis to detect the Tyr204-phosphorylation of ERK1 and 2. Blots were stripped and reprobed to detect ERK2. These results are
representative of three independent experiments.
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ERK even after 30 h of Carb treatment (Fig. 4D). These
results clearly indicate that Carb induced p53 transactivation
activity is required for the activation of ERK in cervical cancer
SiHa and CaSki cells.4. Discussion
Investigations are extensively made to examine the impor-
tance of MAPK cascade in the regulation of apoptosis during
stress conditions. Many of these studies have provided general
view that the activation of ERK pathway confers survival sig-
nals which counteracts the proapoptotic signaling associated
with JNK and p38 activation [30–35]. In accordance to this
general view, the inhibition of ERK signaling is shown to
increase the sensitivity of cytotoxic agents in a variety of cell
lines [36–38]. However, in the present study we have provided
evidence that activation of ERK is important for the induction
of Carb induced apoptosis in SiHa and CaSki cell lines. Earlier
it has been reported that the Carb analogue cisplatin also acti-
vates ERK which is linked with the induction of apoptosis in a
range of cell lines [8–10]. In addition to Carb or cisplatin,
many other DNA damaging agents have also shown the simi-
lar ERK mediated response in various cell lines [2–7]. Along
with these reports, our observations propose the pro-apoptotic
role of ERK which is in contrast to the general view that the
activation of ERK pathway provides survival advantage to
the cells. Thus, we sought to probe the upstream regulation
of ERK activation in Carb induced DNA damage stress lead-
ing to the induction of apoptosis in cervical cancer cell lines.
Typically, ERK is activated through the protein kinase cascade
initiated by the activation of tyrosine kinase activity of EGFR
[25,26]. Data presented in Fig. 2 clearly indicated that though
there is a correlation between the basal activity of ERK and
the tyrosine kinase activity of EGFR, however this relation
was not observed for Carb induced activation of ERK in bothSiHa and CaSki cells. These results imply that the upstream
signaling for the DNA-damage induced activation of ERK is
independent of EGFR mediated signaling.
Since, p53 acts as a central mediator of DNA damage
response, its involvement was next explored in Carb induced
activation of ERK. As demonstrated in this report as well as
in earlier studies, it has been shown that Carb as well as other
platinum drugs mediated DNA damage stress induces p53
transactivation activity in various cervical cancer cells includ-
ing SiHa and CaSki cells, which is associated with the induc-
tion of apoptosis [16]. Therefore, the results so far suggest
that the transactivation activity of p53 as well as the activation
of ERK is essentially involved in Carb induced apoptosis in
both SiHa and CaSki cells. To explore the inter-relationship
between p53 and ERK in response to Carb treatment, we next
analyzed the time kinetics of p53 expression as well as the acti-
vation of ERK, in both the cells. Based on the densitometric
analysis of Western blots, the stabilization of p53 (as demon-
strated by Western blot analysis in Fig. 3A and B) and phos-
phorylation of ERK (as demonstrated by Western blot
analysis in Fig. 1C and D) was plotted against the time interval
of Carb treatment in both SiHa and CaSki cells (Fig. 5A and
B). Even though, the phosphorylated ERK levels are signiﬁ-
cantly higher in untreated SiHa cells as compared to CaSki
cells, in both these cell lines the kinetics between p53 and
ERK activation interestingly demonstrates that the stabiliza-
tion of p53 protein occurs much earlier than the strong activa-
tion of ERK in response to Carb treatment. This led us to
hypothesize that p53 may act as an upstream regulator of Carb
induced ERK activation in response to the DNA damage
stress leading to the induction of apoptosis. This assumption
is further supported by our data demonstrating that the inhibi-
tion of p53 transactivation activity results in diminished acti-
vation of ERK in Carb treated cells. The experiments
performed with PFTa as well as the dominant-negative-mu-
tant of p53 clearly suggest that Carb induced activation of
ERK depends on the transactivation activity of p53 (Fig. 4)
Fig. 5. p53 acts as upstream regulator of Carb induced ERK activation. (A and B) SiHa and CaSki cells were treated with 500 lMCarb for indicated
time. Cells were harvested and processed for Western blot analysis to detect the levels of activated ERK and p53 as shown in Figs. 1 and 3.
Expression of activated ERK and p53 was determined by quantitation of bands using densitometry scanner analysis. Average of the density of the
bands are plotted against time of treatment from three independent experiments and represented as line graph.
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an earlier report where p53 transactivation activity has been
linked with the sustained activation of ERK [28]. Moreover,
very recently it has been demonstrated that p53 activates
MEK-1-ERK cascade through a process that depends on pro-
tein synthesis and H-Ras in certain type of neuroblastoma cells
[39]. Therefore, it is likely that p53 mediated activation of
ERK results through similar mechanisms in SiHa and CaSki
cells, in response to Carb treatment. At the same time, our
results are in contrast to the reports in which p53 independent
activation of ERK in response to DNA damage has been dem-
onstrated [8,10]. These reports suggest that, additional path-
ways may also regulate the DNA damage induced activation
of ERK which needs further exploration. Moreover, since
the consequence of p53 activation depends on the genetic sta-
tus of the cells as well as the duration of stress, it has been sug-
gested that p53 may act as an upstream regulator of MAPK
signaling via the transcriptional activation of its regulatory
phosphatases [40–44].
In summary, our data demonstrate that in response to Carb
treatment, both p53 and ERK are activated in a speciﬁc man-
ner. Abrogation of Carb induced p53 transactivation activity
by chemical as well as genetic inhibitors results in decreased
activation of ERK in SiHa and CaSki cells. Moreover, we sug-
gest for the ﬁrst time that p53 acts as upstream regulator of
DNA damage induced ERK activation which assigns the
apoptotic role to ERK instead of its conventional survival
functions. Further characterization for the factors which link
p53 to the activation of ERK may contribute to better under-
standing of ERK activation mediated induction of apoptosis
in response to DNA damage stress.
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